Study to assess the neurological and cognitive effects of using Hypofractionated Stereotactic Radiotherapy used to treat multiple (3-10) brain metastases.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2015
This article has no abstract
Epistemonikos ID: 4e2599ffe92a7c9ac97d93ee9aa98a47e43a8f82
First added on: Feb 23, 2025